Traws Pharma Files 8-K
Ticker: TRAW · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1130598
| Field | Detail |
|---|---|
| Company | Traws Pharma, Inc. (TRAW) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, financial-reporting
TL;DR
Traws Pharma (fka Onconova) filed an 8-K on 3/21/25. Check it out.
AI Summary
Traws Pharma, Inc. filed an 8-K on March 21, 2025, reporting other events and financial statements. The company, formerly known as Onconova Therapeutics, Inc., is incorporated in Delaware and headquartered in Newtown, PA.
Why It Matters
This filing provides an update on Traws Pharma's corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing reporting corporate events and financial statements, not indicating any immediate financial distress or significant operational changes.
Key Players & Entities
- Traws Pharma, Inc. (company) — Registrant
- Onconova Therapeutics, Inc. (company) — Former company name
- March 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Newtown, PA (location) — Business address
FAQ
What is the primary purpose of this 8-K filing for Traws Pharma, Inc.?
The primary purpose is to report 'Other Events' and 'Financial Statements and Exhibits' as of March 21, 2025.
What was Traws Pharma, Inc. previously known as?
Traws Pharma, Inc. was formerly known as Onconova Therapeutics, Inc.
In which state is Traws Pharma, Inc. incorporated?
Traws Pharma, Inc. is incorporated in Delaware.
What is the business address of Traws Pharma, Inc.?
The business address is 12 Penns Trail, Newtown, PA 18940.
What is the SEC file number for Traws Pharma, Inc.?
The SEC file number is 001-36020.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding Traws Pharma, Inc. (TRAW).